Muscle morphogenesis is tightly coupled with that of motor neurons (MNs). Both MNs and muscle progenitors simultaneously explore the surrounding tissues while exchanging reciprocal signals to tune their behaviors. We previously identified the Fat1 cadherin as a regulator of muscle morphogenesis, and showed that it is required in the myogenic lineage to control the polarity of progenitor migration. To expand our knowledge on how Fat1 exerts its tissue-morphogenesis regulator activity, we dissected its functions by tissuespecific genetic ablation. An emblematic example of muscle under such morphogenetic control is the cutaneous maximus (CM) muscle, a flat subcutaneous muscle in which progenitor migration is physically separated from the process of myogenic differentiation, but tightly associated with elongating axons of its partner motor neurons. Here, we show that constitutive Fat1 disruption interferes with expansion and differentiation of the CM muscle, with its motor innervation and with specification of its associated MN pool.Fat1 is expressed in muscle progenitors, in associated mesenchymal cells, and in MN subsets including the CM-innervating pool. We identify mesenchyme-derived connective tissue as a cell type in which Fat1 activity is required for the non-cell-autonomous control of CM muscle progenitor spreading, myogenic differentiation, motor innervation, and for motor pool specification. In parallel, Fat1 is required in MNs to promote their axonal growth and specification, indirectly influencing muscle progenitor progression. These results illustrate how Fat1 coordinates the coupling of muscular and neuronal morphogenesis by playing distinct but complementary actions in several cell types.
Author summaryBuilding neuromuscular circuits involves a tight control of morphogenetic and regulatory events driving muscle and motor neuron development. Alterations of these processes can lead to congenital abnormalities or be at the root of human pathologies. Here, we show that the mouse Fat1 cadherin gene, a developmental regulator of muscle morphogenesis, coordinates the coupling between muscle and neuronal development by playing complementary functions in mesenchyme, muscles and motor neurons. These findings may be particularly relevant for Facioscapulohumeral dystrophy (FSHD), a muscle disease affecting subgroups of muscles in the face and shoulder, which is thought to involve developmental alterations. Although FSHD is known to traditionally result from a complex combination of genetic defects, the link between the altered molecular mechanisms and the specific set of muscles affected in patients is still poorly understood. Fat1 deficiency in mice causes phenotypes reminiscent of FSHD symptoms. Furthermore, pathogenic FAT1 variants have been identified in patients with FSHD-like phenotypes, and FAT1 expression is deregulated in classical forms of FSHD. Thus, a better understanding of the developmental functions of Fat1 could guide research on FSHD pathogenesis. In particular, by showing that Fat1 disru...